SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-20-089055
Filing Date
2020-07-31
Accepted
2020-07-31 16:02:44
Documents
3

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm2026214d1_sc13da.htm SC 13D/A 35244
2 EXHIBIT 10 tm2026214d1_ex10.htm EX-10 35423
3 EXHIBIT 11 tm2026214d1_ex11.htm EX-11 15458
  Complete submission text file 0001104659-20-089055.txt   87640
Mailing Address 965 ATLANTIC AVENUE SUITE 101 ALAMEDA CA 94501
Business Address 965 ATLANTIC AVENUE SUITE 101 ALAMEDA CA 94501 510-671-8370
AgeX Therapeutics, Inc. (Subject) CIK: 0001708599 (see all company filings)

IRS No.: 821436829 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90737 | Film No.: 201065946
SIC: 2834 Pharmaceutical Preparations

Mailing Address VIKING HOUSE NELSON ST. DOUGLAS Y8 IM1 2AH
Business Address CRAIGMUIR CHAMBERS PO BOX 71 ROAD TOWN, TORTOLA D8 VG1110 441624639396
Juvenescence Ltd (Filed by) CIK: 0001724307 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: SC 13D/A